CA1306260C
(en)
*
|
1985-10-18 |
1992-08-11 |
Shionogi & Co., Ltd. |
Condensed imidazopyridine derivatives
|
US4942168A
(en)
*
|
1987-07-13 |
1990-07-17 |
Hoechst-Roussel Pharmaceuticals Inc. |
Hydroxyquinoline amines, and method of enhancing memory in mammals
|
CA1335996C
(en)
*
|
1988-02-16 |
1995-06-20 |
Susumu Takada |
2-substituted carbonylimidazo¬4,5-c|quinolines
|
EP0361489A3
(en)
*
|
1988-09-30 |
1991-06-12 |
Chugai Seiyaku Kabushiki Kaisha |
Novel 3,4-diaminoquinoline and pyridine compounds
|
DE69029212T2
(de)
*
|
1989-02-27 |
1997-05-22 |
Riker Laboratories Inc |
4-Amino-1H-Imidazo(4,5-c)chinoline als antivirale Mittel
|
US4994468A
(en)
*
|
1989-03-07 |
1991-02-19 |
Kyowa Hakko Kogyo Co., Ltd. |
Imidazoquinolone derivatives
|
US4929624A
(en)
*
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
CA2021338C
(en)
*
|
1989-07-18 |
1996-07-16 |
Fumio Suzuki |
Imidazoquinolone derivatives
|
US4988815A
(en)
*
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
FR2654021B1
(fr)
*
|
1989-11-07 |
1992-02-28 |
Simond Jacques |
Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
|
GB8928281D0
(en)
*
|
1989-12-14 |
1990-02-21 |
Smith Kline French Lab |
Compounds
|
ATE143661T1
(de)
*
|
1990-06-01 |
1996-10-15 |
Kyowa Hakko Kogyo Kk |
Imidazonaphthyridinderivate
|
DK0582581T3
(da)
*
|
1991-03-01 |
1999-11-08 |
Minnesota Mining & Mfg |
1,2-substituerede 1H-imidazo[4,5-c]quinolin-4-aminer
|
US5266575A
(en)
*
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
US5395937A
(en)
*
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
US5693811A
(en)
*
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
WO1998030562A1
(fr)
*
|
1997-01-09 |
1998-07-16 |
Terumo Kabushiki Kaisha |
Nouveaux derives d'amide et intermediaires utilises pour leur synthese
|
JPH10298181A
(ja)
*
|
1997-04-25 |
1998-11-10 |
Sumitomo Pharmaceut Co Ltd |
タイプ2ヘルパーt細胞選択的免疫応答抑制剤
|
JP2000119271A
(ja)
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
1h―イミダゾピリジン誘導体
|
US7253199B2
(en)
*
|
2001-10-23 |
2007-08-07 |
Applied Research Systems Ars Holding N.V. |
Azole derivatives and pharmaceutical compositions containing them
|
GB0211649D0
(en)
*
|
2002-05-21 |
2002-07-03 |
Novartis Ag |
Organic compounds
|
JP2006502121A
(ja)
|
2002-07-23 |
2006-01-19 |
テバ ジョジセルジャール レースベニュタールシャシャーグ |
1H−イミダゾ[4,5−c]キノリン−4−フタルイミド中間体を介する1H−イミダゾ−[4,5−c]キノリン−4−アミンの調製
|
AU2003254221A1
(en)
|
2002-07-26 |
2004-02-16 |
Biogal Gyogyszergyar Rt. |
Preparation of 1h-imidazo (4,5-c) quinolin-4-amines via novel 1h-imidazo (4,5-c) quinolin-4-cyano and 1h-imidazo (4,5-c) quinolin-4-carboxamide intermediates
|
US7648997B2
(en)
|
2003-08-12 |
2010-01-19 |
Coley Pharmaceutical Group, Inc. |
Hydroxylamine substituted imidazoquinolines
|
NZ545412A
(en)
|
2003-08-27 |
2008-12-24 |
Coley Pharm Group Inc |
Aryloxy and arylalkyleneoxy substituted imidazoquinolines
|
US20050054665A1
(en)
|
2003-09-05 |
2005-03-10 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
CA2536530A1
(en)
|
2003-10-01 |
2005-04-14 |
Taro Pharmaceuticals U.S.A., Inc. |
Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
|
BRPI0414856A
(pt)
*
|
2003-10-03 |
2006-11-21 |
3M Innovative Properties Co |
imidazoquinolinas alcóxi-substituìdas
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
ITMI20032121A1
(it)
*
|
2003-11-04 |
2005-05-05 |
Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm |
Procedimento per la preparazione di imiquimod e suoi intermedi
|
US7897767B2
(en)
|
2003-11-14 |
2011-03-01 |
3M Innovative Properties Company |
Oxime substituted imidazoquinolines
|
CN1906192A
(zh)
|
2003-11-14 |
2007-01-31 |
3M创新有限公司 |
羟胺取代的咪唑环化合物
|
KR101130928B1
(ko)
|
2003-11-25 |
2012-04-12 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
치환된 이미다조 고리 시스템 및 방법
|
EP1701955A1
(en)
|
2003-12-29 |
2006-09-20 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
WO2005066169A2
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
US8697873B2
(en)
|
2004-03-24 |
2014-04-15 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
US8017779B2
(en)
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
WO2006065280A2
(en)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
WO2006038923A2
(en)
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
ES2392648T3
(es)
|
2004-12-30 |
2012-12-12 |
3M Innovative Properties Company |
Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
|
JP5543068B2
(ja)
|
2004-12-30 |
2014-07-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
|
JP2008530022A
(ja)
|
2005-02-04 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫反応調節物質を含む水性ゲル処方物
|
WO2006086634A2
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
EP1869043A2
(en)
|
2005-04-01 |
2007-12-26 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
JP2008538550A
(ja)
|
2005-04-01 |
2008-10-30 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物
|
EP1931352B1
(en)
|
2005-08-22 |
2016-04-13 |
The Regents of The University of California |
Tlr agonists
|
CA2653941C
(en)
|
2006-05-31 |
2013-01-08 |
The Regents Of The University Of California |
Substituted amino purine derivatives and uses thereof
|
WO2008008432A2
(en)
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
PT2510946E
(pt)
|
2007-02-07 |
2015-11-23 |
Univ California |
Conjugados de agonistas sintéticos de tlr e suas utilizações
|
EP2009002A1
(en)
*
|
2007-06-21 |
2008-12-31 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
EP2396328A2
(en)
|
2009-02-11 |
2011-12-21 |
The Regents of The University of California |
Toll-like receptor modulators and treatment of diseases
|
EP3222621B1
(en)
|
2010-08-17 |
2023-03-08 |
3M Innovative Properties Company |
Lipidated immune response modifier compound and its medical use
|
US8728486B2
(en)
|
2011-05-18 |
2014-05-20 |
University Of Kansas |
Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
|
AU2012318694B2
(en)
*
|
2011-10-04 |
2016-12-22 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
DK2950649T3
(da)
*
|
2013-02-01 |
2020-05-04 |
Wellstat Therapeutics Corp |
Aminforbindelser med antiinflammations-, antisvampe-, antiparasit- og anticanceraktivitet
|
AU2014230017A1
(en)
|
2013-03-15 |
2015-09-17 |
Syngenta Participations Ag |
Microbicidally active imidazopyridine derivatives
|
ES2538880B1
(es)
*
|
2013-12-24 |
2016-09-08 |
Laboratorios Viñas S.A. |
Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
|
WO2015103989A1
(en)
|
2014-01-10 |
2015-07-16 |
Shanghai Birdie Biotech, Inc. |
Compounds and compositions for immunotherapy
|
EP3166976B1
(en)
|
2014-07-09 |
2022-02-23 |
Birdie Biopharmaceuticals Inc. |
Anti-pd-l1 combinations for treating tumors
|
MX2018003215A
(es)
*
|
2015-09-14 |
2018-06-08 |
Pfizer |
Derivados de imidazo[4,5-c]quinolina e imidazo[4,5-c][1,5]naftirid ina novedosos como inhibidores de lrrk2.
|
CN106943597A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技(北京)有限公司 |
用于治疗肿瘤的抗-egfr组合
|
CN115554406A
(zh)
|
2016-01-07 |
2023-01-03 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-cd20组合
|
WO2017184735A1
(en)
*
|
2016-04-19 |
2017-10-26 |
Ifm Therapeutics, Inc |
Nlrp3 modulators
|
BR112018071347A2
(pt)
|
2016-04-19 |
2019-02-05 |
Innate Tumor Immunity Inc |
moduladores de nlrp3
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
TWI674261B
(zh)
|
2017-02-17 |
2019-10-11 |
美商英能腫瘤免疫股份有限公司 |
Nlrp3 調節劑
|
CN108794467A
(zh)
|
2017-04-27 |
2018-11-13 |
博笛生物科技有限公司 |
2-氨基-喹啉衍生物
|
CA3067268A1
(en)
|
2017-06-23 |
2018-12-27 |
Birdie Biopharmaceuticals, Inc. |
Crystalline resiquimod monosulfate anhydrate and its preparation and uses
|
FR3113287B1
(fr)
|
2020-08-07 |
2023-06-23 |
Phv Pharma |
Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
|